China Sxt Pharmaceuticals Stock Market Value
| SXTC Stock | USD 2.82 0.04 1.44% |
| Symbol | China |
China SXT Pharmaceuticals Price To Book Ratio
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.426 | Earnings Share (28.58) | Revenue Per Share | Quarterly Revenue Growth 0.295 | Return On Assets |
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
China SXT 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China SXT's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China SXT.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in China SXT on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding China SXT Pharmaceuticals or generate 0.0% return on investment in China SXT over 90 days. China SXT is related to or competes with Akanda Corp, Shuttle Pharmaceuticals, Painreform, Regencell Bioscience, Procaps Group, Biofrontera, and Shionogi. China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing,... More
China SXT Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China SXT's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China SXT Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.58 | |||
| Information Ratio | 0.0655 | |||
| Maximum Drawdown | 180.99 | |||
| Value At Risk | (10.88) | |||
| Potential Upside | 15.34 |
China SXT Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for China SXT's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China SXT's standard deviation. In reality, there are many statistical measures that can use China SXT historical prices to predict the future China SXT's volatility.| Risk Adjusted Performance | 0.0623 | |||
| Jensen Alpha | 1.45 | |||
| Total Risk Alpha | 3.75 | |||
| Sortino Ratio | 0.1381 | |||
| Treynor Ratio | 0.5568 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China SXT's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
China SXT Pharmaceuticals Backtested Returns
China SXT is out of control given 3 months investment horizon. China SXT Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0673, which signifies that the company had a 0.0673 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.4% are justified by taking the suggested risk. Use China SXT Risk Adjusted Performance of 0.0623, downside deviation of 9.58, and Mean Deviation of 8.55 to evaluate company specific risk that cannot be diversified away. China SXT holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.18, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, China SXT will likely underperform. Use China SXT semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on China SXT.
Auto-correlation | -0.1 |
Very weak reverse predictability
China SXT Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between China SXT time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China SXT Pharmaceuticals price movement. The serial correlation of -0.1 indicates that less than 10.0% of current China SXT price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.98 |
China SXT Pharmaceuticals lagged returns against current returns
Autocorrelation, which is China SXT stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting China SXT's stock expected returns. We can calculate the autocorrelation of China SXT returns to help us make a trade decision. For example, suppose you find that China SXT has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
China SXT regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If China SXT stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if China SXT stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in China SXT stock over time.
Current vs Lagged Prices |
| Timeline |
China SXT Lagged Returns
When evaluating China SXT's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of China SXT stock have on its future price. China SXT autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, China SXT autocorrelation shows the relationship between China SXT stock current value and its past values and can show if there is a momentum factor associated with investing in China SXT Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:Check out China SXT Correlation, China SXT Volatility and China SXT Alpha and Beta module to complement your research on China SXT. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
China SXT technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.